Search - tctmd.com

Displaying 41 - 60 of 2707

Sort: Relevancy | Date

Presentation TCT 2025

Pipeline Devices for HTN

Presenter: Lucas Lauder

October 27, 2025

Presentation TCT 2025

TCT 1916: Successful Percutaneous Transluminal Renal Angioplasty for Atherosclerotic Bilateral Renal Artery Stenosis in a Super-Elderly Patient With Refractory Hypertension, Acute Heart Failure, and Renal Failure

Presenter: Kota Komiyama

October 27, 2025

Presentation TCT 2025

On-Table Predictors of Successful Denervation - Where are We in 2025?

Presenter: Felix Mahfoud

October 27, 2025

Presentation TCT 2025

TCT 590: Single-Center Real world use of the Paradise Renal Denervation Catheter. Early experience from the Cleveland Clinic.

Presenter: Anmol Multani

October 27, 2025

Presentation TCT 2025

TCT 1915: Iatrogenic Perforation During Percutaneous Intervention of Renal Artery CTO: Its Management and Long-Term Follow-Up

Presenter: Rajesh Vijayvergiya

October 27, 2025

Presentation TCT 2025

TCT 588: 24-Month Durability of the Blood Pressure Lowering Effect of Ultrasound Renal Denervation for Hypertension with the Paradise System

Presenter: Ajay J. Kirtane

October 27, 2025

Presentation TCT 2025

TCT 1914: Minimally Invasive Management of Renal Artery Aneurysm

Presenter: Deepakraj Gajanana

October 27, 2025

Presentation TCT 2025

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

Presenter: David P. Lee

October 27, 2025

Presentation TCT 2025

Where Do We See Renal Denervation in the Hypertension Pathway, Now and in Five Years?

Presenter: David E. Kandzari

October 27, 2025

Presentation TCT 2025

TCT 589: Same Day Discharge with the Symplicity Renal Denervation System: Outcomes from the Real World Global Symplicity Registry DEFINE

Presenter: Joachim Weil

October 27, 2025

Presentation TCT 2025

My Tips and Tricks for Prevention and Management of Complications in Above-the-Knee and Renal Interventions

Presenter: Sanjay Misra

October 27, 2025

Presentation TCT 2025

University of Pennsylvania's Hypertension Program

Presenter: Raymond R. Townsend

October 27, 2025

Presentation TCT 2025

Beyond the Pivotal Trial: Real-World Impact in Uncontrolled Hypertension

Presenter: Karl Fengler

October 27, 2025

Presentation TCT 2025

Global Hypertension Crisis

Presenter: Eric A. Secemsky

October 27, 2025

Presentation TCT 2025

TCT 584: Renal Denervation for Resistant Hypertension in Fibromuscular Dysplasia: A Case Series

Presenter: Merlin Nikita

October 27, 2025

Presentation TCT 2025

TCT 583: Long-term Safety and Efficacy of Renal Sympathetic Denervation in Patients with Heart Failure with Reduced Ejection Fraction: 5-year results from the IMPROVE-HF-I study

Presenter: Kari A. Saville

October 27, 2025

Presentation TCT 2025

TCT 582: Ultrasound vs. Radiofrequency Renal Denervation: A Comparative Analysis

Presenter: Anmol Multani

October 27, 2025

Presentation TCT 2025

TCT 581: Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: Pooled Analysis of the HFIB and Ultra-HFIB Studies

Presenter: Vivek Y. Reddy

October 27, 2025

Presentation TCT 2025

TCT 585: Renal Denervation Combined with Atrial Fibrillation Ablation in Heart Failure: Interim 6-Month Data on Reverse Remodeling and Arrhythmia Recurrence

Presenter: Tomasz Skowerski

October 27, 2025

Presentation TCT 2025

TCT 586: Diuretic Management in Patients Treated with Greater Splanchnic Nerve Ablation for HFpEF: REBALANCE-HF Randomized Trial

Presenter: Sheldon E. Litwin

October 27, 2025

Advertisement

Pipeline Devices for HTN

TCT 1916: Successful Percutaneous Transluminal Renal Angioplasty for Atherosclerotic Bilateral Renal Artery Stenosis in a Super-Elderly Patient With Refractory Hypertension, Acute Heart Failure, and Renal Failure

On-Table Predictors of Successful Denervation - Where are We in 2025?

TCT 590: Single-Center Real world use of the Paradise Renal Denervation Catheter. Early experience from the Cleveland Clinic.

TCT 1915: Iatrogenic Perforation During Percutaneous Intervention of Renal Artery CTO: Its Management and Long-Term Follow-Up

TCT 588: 24-Month Durability of the Blood Pressure Lowering Effect of Ultrasound Renal Denervation for Hypertension with the Paradise System

TCT 1914: Minimally Invasive Management of Renal Artery Aneurysm

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

Where Do We See Renal Denervation in the Hypertension Pathway, Now and in Five Years?

TCT 589: Same Day Discharge with the Symplicity Renal Denervation System: Outcomes from the Real World Global Symplicity Registry DEFINE

My Tips and Tricks for Prevention and Management of Complications in Above-the-Knee and Renal Interventions

University of Pennsylvania's Hypertension Program

Beyond the Pivotal Trial: Real-World Impact in Uncontrolled Hypertension

Global Hypertension Crisis

TCT 584: Renal Denervation for Resistant Hypertension in Fibromuscular Dysplasia: A Case Series

TCT 583: Long-term Safety and Efficacy of Renal Sympathetic Denervation in Patients with Heart Failure with Reduced Ejection Fraction: 5-year results from the IMPROVE-HF-I study

TCT 582: Ultrasound vs. Radiofrequency Renal Denervation: A Comparative Analysis

TCT 581: Renal Sympathetic Denervation as Adjunctive Upstream Therapy during Atrial Fibrillation Ablation: Pooled Analysis of the HFIB and Ultra-HFIB Studies

TCT 585: Renal Denervation Combined with Atrial Fibrillation Ablation in Heart Failure: Interim 6-Month Data on Reverse Remodeling and Arrhythmia Recurrence

TCT 586: Diuretic Management in Patients Treated with Greater Splanchnic Nerve Ablation for HFpEF: REBALANCE-HF Randomized Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content